Evaluation of clinical value of a standardized protocol for dose reduction in patients with axial Spondyloarthritis and clinical remission with anti-TNF therapy

• Conditions: Axial Spondyloarthritis; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2011-005871-18-ES
• Lead Sponsor: CLINICAL PHARMACOLOGY SPANISH SOCIETY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12-21
• Last Update Posted: 4 August 2015

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 190
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To demonstrate that patients with espondilartritis in remission under antiTNF therapy can maintain the remission with a maintenance dose inferior to the currently recommended dose schedule;Secondary Objective: ;Primary end point(s): FALTA TEXTO INGLES;Timepoint(s) of evaluation of this end point: 1 YEAR

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): FALTA TEXTO INGLES;Timepoint(s) of evaluation of this end point: 1 and 2 years